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Abstract

Author Manuscript

Microglia play important and dynamic roles in mediating a variety of physiological and
pathological processes during the development, normal function and degeneration of the central
nervous system. Application of SILAC-based proteomic analysis would greatly facilitate the
identification of cellular pathways regulating the multifaceted phenotypes of microglia. We and
others have successfully SILAC-labeled immortalized murine microglial cell lines in previous
studies. In this study, we report the development and evaluation of a SILAC-labeled primary rat
microglia model. Although the isotope labeling scheme for primary microglia is drastically
different from that of immortalized cell lines, our de novo and uninterrupted primary culture
labeling protocol (DUP-SILAC) resulted in sufficient incorporation of SILAC labels for mass
spectrometry-based proteomic profiling. In addition, label incorporation did not alter their
morphology and response to endotoxin stimulation. Proteomic analysis of the endotoxinstimulated SILAC-labeled primary microglia identified expected as well as potentially novel
activation markers and pro-inflammatory pathways that could be quantified in a more
physiologically relevant cellular model system compared to immortalized cell lines. The
establishment of primary microglia SILAC model will further expand our capacity for global scale
proteomic profiling of pathways under various physiological and pathological conditions.
Proteomic data are available via ProteomeXchange with identifier PXD002759.
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Research on microglia, discovered nearly a century ago [1], had historically focused on their
role as resident immune cells in the CNS in response to neuronal injury and invading
pathogens and their contribution to the pathogenesis of various neurological disorders
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including Parkinson’s and Alzheimer’s disease [2, 3]. Representing >10% of the cells in the
CNS, microglia have increasingly been recognized as performing a highly dynamic role in
early life CNS remodeling, formation of neuronal plasticity and maintenance of cellular
homeostasis in an adult brain under physiologic and pathological conditions, in addition to
their classical immune-related functions [4]. Underpinning their dynamic involvement in
various cellular processes is a spectrum of “staged” and distinct microglial morphological
and functional phenotypes [5]. The molecular mechanisms underlying the various microglial
activation stages and the factors/pathways that regulate their shift from one stage to the next
are not well understood.
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MS-based proteomic analysis enables expression profiling of thousands of proteins in a
single sample preparation, making it a powerful tool to identify cellular pathways associated
with specific microglial activation stages. Highly desired, but currently not systematically
evaluated for mass spectrometric pathway profiling, is a SILAC-based model with primary
microglia which more closely resemble microglia in vivo than immortalized microglial cell
lines. We have previously reported the establishment of an immortalized murine microglial
cell line-based SILAC system where a near complete SILAC label incorporation (>98%) is
conveniently achieved by propagating the immortalized cells in label-containing media
through multiple and consecutive passaging [6, 7]. Primary microglia, however, may pose a
particular challenge to achieving a sufficient isotopic label incorporation due to how primary
microglia are prepared in culture [8–10]: a mixed glia culture (microglia and astroglia) are
first established from newborn pup’s brain cells and microglia are then separated from
astroglia two weeks later. No passaging is involved in the two-week time span during which
various cell types including microglia undergo their in vitro maturation process.
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To prepare SILAC-labeled primary microglia, we employed our de novo and uninterrupted
primary culture SILAC labeling strategy (DUP-SILAC) of making light or heavy labeled
amino acid pairs (arginine and lysine) available to microglial cells throughout their in vitro
maturation process without the introduction of any disruptive steps that may interfere with
the maturation of various cell types in the mixed culture system. Brains were harvested from
newborn Sprague Dawley rat pups (Charles River), cortical and midbrain tissues were
mechanically triturated and dispersed cells (8 × 106) were seeded to poly-D-lysine coated
75-cm2 culture flasks [10] and maintained at 37°C in a humidified atmosphere of 5% CO2
and 95% air in either the “Light” or “Heavy” SILAC media (10 mL/flask). Light SILAC
media consisted of arginine and lysine-free DMEM supplemented with 10% dialyzed FBS, 2
mM L-glutamine, 1% MEM non-essential amino acids, 1 mM sodium pyruvate, 50 units/mL
penicillin, 50 μg/mL streptomycin, 10 mM HEPES, pH 7.4 and 100 μg/mL each of Larginine and L-lysine (Life Technologies). The Heavy SILAC media was made up of the
same ingredients except that the light L-arginine and L-lysine were replaced with heavy
labeled 13C6-15N4-L-arginine and 13C6-15N2-L-lysine (Cambridge Isotope) [7]. Four days
later, fresh Light or Heavy SILAC media (5 mL/flask) were added to respective cultures.
Two weeks after the start of the cultures, the flasks were placed on an orbital shaker and
shaken at 120 rpm for 60 min. Media containing the detached microglia were collected and
seeded in Light or Heavy SILAC media to poly-D-lysine coated 6-well culture plates (106
cells/3 mL media/well) or Nunc 8-well glass chamber slides (2.5×104 cells/0.3 mL media/
chamber) and grown overnight before treatment.
Proteomics. Author manuscript; available in PMC 2016 May 25.
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The primary rat microglia harvested from mixed glia cultures that had been grown for two
weeks in the DMEM-based Light (D-Light) and Heavy (D-Heavy) SILAC media were first
compared with those from mixed glia cultures grown in the traditional DMEM/F12-based
media (D/F12) [10] prepared from same pool of rat brains. As shown in Fig. 1A, the D-Light
and D-Heavy microglia morphologically resembled the D/F12 microglia, exhibiting the
characteristic morphology of primary microglia in vitro [9,11]. The culture was highly pure
(>98%) for microglia as revealed by immunostaining for Iba-1 (ionized calcium-binding
adaptor molecule 1), a microglia-specific marker (Fig. 1B), consistent with our previous
reports [12,13]. Only a tiny fraction of cells were immune-positive for astroglial marker glial
fibrillary acidic protein (D/F12: 0.41%, n = 980; D-Light: 0.14%, n = 690; D-Heavy: 0.38%,
n = 792). Functionally, D/F12, D-Light, and D-Heavy microglia were equally responsive to
endotoxin lipopolysaccharide (LPS, 0.2–5 ng/mL)-induced production of nitric oxide (NO),
a reporter for the M1 microglial activation marker, inducible NO synthase (iNOS, [14]) (Fig.
1C).
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We next determined label incorporation efficiency, a key determinant of whether these
microglia would be suitable for SILAC-based proteomic profiling. Microglia (106) were
harvested from D-Heavy mixed glia cultures at 9 days (the earliest in vitro microglia
maturation time point under the condition), 2 and 3 weeks following initial seeding [8–10],
washed 3× with PBS, and then resuspended in 40 μL of lysis buffer (100 mM Tris-HCl,
pH7.6, 4% SDS, and 100 mM dithiothreitol) [7]. Microglia were lysed at 95°C for 5 min
followed by a brief sonication and centrifuged for 5 min at 17 000 × g. For MS, 50 μg of
protein were processed using the FASP method [15, 16], digested with trypsin-LysC,
desalted using HYPER-SEP C18 columns as described [6], concentrated by vacuum
centrifugation, and resuspended in 0.1% formic acid. For samples with a lower protein
concentration, 12 μg of protein were processed using the GASP method [17]. Peptides were
separated on an Acclaim PepMap C18 (75 μm × 50 cm) UPLC column (Thermo) using an
EASY-nLC 1000 with gradient time ranging from 60 to 240 min (2–40% acetonitrile in
0.1% formic acid). Mass spectrometric analysis was performed by a hybrid quadrupoleOrbitrap instrument (Q Exactive Plus, Thermo), using a top 10 data-dependent acquisition
method with a dynamic exclusion time of 20 s. Full scan and MS/MS resolution was 70 000
and 17 500, respectively. Protein identifications were assigned through MaxQuant (version
1.5.0.30) using the UniProt Rattus norvegicus database (November 2014, 38 912 entries).
Carbamidomethyl (C) was set as a fixed modification and acetyl (protein N-terminus) and
oxidation (M) were set as variable modifications. Additional specifications included
designating trypsin/P as the enzyme used with the possibility of two missed cleavages, Lys8
and Arg10 as the heavy SILAC labels, 20 ppm (first search)/4.5 ppm (recalibrated second
search) mass tolerance for precursor ions and 20 ppm mass tolerance for fragment ions. The
mass spectrometric raw data have been deposited to the ProteomeXchange Consortium [18]
via the PRIDE partner repository with the dataset identifier PXD002759.
Using an abundant cellular protein beta actin (actin, cytoplasmic 1) as an example, the
percentage of the label incorporation for the peptide VAPEEHPVLLTEAPLNPK was
approximately 55 and 78% in microglia isolated from 9 day and 2-week old mixed glia
cultures, respectively (Fig. 2A). The global-scale incorporation efficiency of heavy-labeled
amino acids was determined by Heavy:Light ratios reported in MaxQuant for all identified
Proteomics. Author manuscript; available in PMC 2016 May 25.
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peptides where percent efficiency at the peptide level was calculated as 1-(1/ratio(H/L)) [19].
Average labeling efficiency was approximately 53.4 ± 6.1%, 67.6 ± 4.4% and 72.5 ± 3.1%
(mean ± SEM) at the 9 day, 2 and 3 week timed intervals, respectively (Fig. 2B). The
labeling efficiency of ~70% achieved in primary rat microglia cultures in this study are
similar to that observed for primary murine neuronal cultures [20, 21], but lower than the
95% efficiency observed for 20-day old primary astroglial cultures [22]. As reported for
primary neuron SILAC labeling studies, two different sets of heavy SILAC labels
(sometimes referred to as “Heavy” and “Medium”) may be used to exclude unlabeled
proteins from the analysis [23,24]. This approach would bypass the need to account for
labeling efficiency and could potentially reduce the risk of introducing variation, making it
worthy of consideration in future experiments involving primary neural cells with limited
proliferation capacity.
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Next, we performed proteomic analysis of SILAC-labeled primary microglia after exposure
to the M1 stage activator LPS, in order to test the quantitation accuracy using normalized
ratios (which accounts for labeling efficiency) from MaxQuant through bioinformatic
analysis of the SILAC datasets. D-Light and D-Heavy microglia in 6-well plates were
treated in duplicate for 24 h with Light SILAC media (control) and Heavy SILAC media
containing 1 ng/mL LPS, respectively. Afterwards, cells were rinsed with PBS, collected in
lysis buffer and equal amounts of proteins from D-Light and D-Heavy microglia were
combined and processed for mass spectrometric analysis.
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Using a peptide and protein false discovery rate of 1.0% in MaxQuant, 2299 protein groups
and 12 442 peptides were identified across replicates (n = 2 biological replicates with two
experimental replicates). Numerous hallmarks of classical microglial activation were
observed in response to LPS treatment, including up-regulation of STAT1, CD14, and
TLR-2. As an example, raw data representing lower fold changes of the up- and downregulated proteins, SOD2 and LRP1, respectively, as well as induction of iNOS are shown in
Fig. 3A–C. LPS-induced iNOS up-regulation in microglia was independently confirmed by
indirect immunofluorescence analysis of the iNOS protein (Fig. 3D). Additionally, based on
the resulting relative quantitation from SILAC-labeled primary microglia, bioinformatic
analysis (IPA version 01-01) revealed LPS exposure to be a predicted upstream event (Fig.
3E). The expression level of only a few targets was inconsistent with the Ingenuity
Knowledge Base, which included the downregulation of LRP1 (low density lipoprotein
receptor-related protein 1). LRP1 has been shown, however, to be involved in the antiinflammatory response of murine macrophages where LRP1 deficiency causes
downregulation of alternative (anti-inflammatory) activation markers and enhances the M1
response [25]. Given the importance of LRP1 in macrophage polarization, differential
expression of LRP1 in microglia could be time-dependent where downregulation occurs at
early time points (post-M1 stimulation) to prevent transition to an alternative activation
phenotype. Future work is needed to investigate LRP1 regulation in the context of microglial
phenotypic changes.
It should be noted that single amino acid (arginine) based-SILAC labeling of primary
microglia has been reported previously [26, 27]. However a comprehensive characterization
of the singly labeled cells in terms of possible phenotypic alterations post labeling, labeling
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efficiency time course, and quantitation accuracy using high-resolution mass spectrometry
were not reported.
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In summary, we report a comprehensive (morphological, biochemical and proteomic)
characterization of a SILAC-based model for primary rat microglia. Even though it was not
possible to consecutively passage the primary glial cultures, which is the approach used for
SILAC labeling of immortalized microglial cell lines, the two-week de novo and
uninterrupted primary culture SILAC (DUP-SILAC) labeling strategy achieved a label
incorporation ratio of ~70%, a value comparable to that observed for murine primary neuron
cultures [20, 21]. The SILAC-labeled primary rat microglia were suitable for MS-based
proteomic analysis with nearly 2300 proteins identified. Furthermore, proteomic analysis
revealed that the SILAC labeled primary rat microglia responded in a similar fashion as
immortalized rat microglial cells to stimulation with LPS as defined by expression changes
of known proteins and related pathways associated with LPS-induced classical activation. In
light of their multifaceted phenotypic stages, the SILAC-based proteomic model with
primary microglia, which are characteristically more closely related to microglia in vivo
compared to immortalized cell lines and are more suitable for studies involving co-cultures
of multiple neural cell types, should further facilitate the identification of distinct cellular
pathways and unique regulators mediating the dynamic microglial responses to various
activity-modulating agents under physiological and pathological conditions.
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Abbreviations
DMEM/F12

DMEM/Ham’s nutrient mixture F12 (1:1)

iNOS

inducible nitric oxide synthase

SILAC

stable isotope labeling by amino acids in cell culture
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Comparison of primary rat microglia prepared from mixed glia cultures grown for 2 weeks
in regular and SILAC media. (A) Photomicrograph of microglia prepared in DMEM/F12 (D/
F12), DMEM light SILAC (D-Light) and DMEM heavy SILAC (D-Heavy) media. (B)
Immunostaining. Microglia cultures were immunostained for microglial marker Iba-1
(Abcam) and counter-stained with DAPI for cell nuclei (Invitrogen) [12]. (C) LPS-induced
nitrite production. Microglia were stimulated with 0 (control), 0.2, 1 and 5 ng/mL LPS for
24 h and amounts of nitrite released were measured and expressed as mean ± SEM as
previously described [11]. *p<0.05 compared to control (n = 3, ANOVA with Bonferroni/
Dunn post hoc analysis). Scale bar: 20 μm in A and 16 μm in B.
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SILAC labeling efficiency. (A) Representative full scan mass spectra showing the peptide
pair with the sequence VAPEEHPVLL-TEAPLNPK* from beta actin in microglia following
9 days (top panel) and 2 weeks (bottom panel) of SILAC labeling. B. Overall labeling
efficiency calculated based on heavy label incorporation in all identified peptides (n = 9780
peptides).
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Figure 3.

LPS-induced microglial differential expression and upstream regulator prediction. (A–C)
Full scan, high resolution mass spectra of SILAC pairs. The peptide GDVITQVALQPALK*
from superoxide dismutase (SOD2), is shown in A. The heavy:light ratio, generated by the
MaxQuant, was 1.98, or 3.40 after normalization. The peptide MYDAQQQQVGTNK* from
low density lipoprotein receptor-related 1 (LRP1) is shown in B. The heavy:light ratio was
0.33, or 0.41 after normalization. The peptide YAGYQMPDGTIR* from iNOS is shown in
C. A heavy:light ratio could not be calculated for this inducible protein since it was not
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present in control cells. (D) Immunostaining analysis of LPS-induced iNOS upregulation in
microglia. Cells were counter-stained with DAPI for cell nuclei. Scale bar: 16 m. (E)
Upstream regulator analysis using Ingenuity Pathway Analysis predicts LPS to be an
activated upstream regulator (central node) where known downstream targets are shown in
the outer nodes. Outer nodes represent enzymes (diamond), kinases (triangle), transporters
(trapezoid), and other proteins (circle) where red and green node color represents up- and
down-regulation, respectively. Orange indicates predicted activation for LPS as an upstream
regulator, while orange, yellow and grey arrows indicate predicted activating effect,
inconsistent relationship, or reported effect with limited information on downstream target
expression change. For biological replicates 1 and 2, the p-values were 3.52×10−22 and
6.22×10−14, respectively, and the Z-scores were 5.267 and 4.358, respectively.
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